Revance Therapeutics, Inc. (RVNC) CEO Mark Foley on Q2 2020 Results - Earnings Call TranscriptSeeking Alpha • 08/09/20
Revance Therapeutics, Inc. (RVNC) CEO Mark Foley on Q1 2020 Results - Earnings Call TranscriptSeeking Alpha • 05/10/20
Implied Volatility Surging for Revance Therapeutics (RVNC) Stock OptionsZacks Investment Research • 03/25/20
Revance Therapeutics, Inc. (RVNC) CEO Mark Foley on Q4 2019 Results - Earnings Call TranscriptSeeking Alpha • 02/25/20
The FDA Accepted Revance Therapeutics' Application for Approval Of Its Botox CompetitorThe Motley Fool • 02/06/20
Revance Therapeutics, Inc. (RVNC) CEO Mark Foley on Q3 2019 Results - Earnings Call TranscriptSeeking Alpha • 11/05/19
Why Hilton Grand Vacations, 21Vianet Group, and Revance Therapeutics Jumped TodayThe Motley Fool • 10/14/19
Revance CEO Dan Browne steps down due to 'misjudgment in handling employee matter'Market Watch • 10/14/19
Revance Therapeutics, Inc. (RVNC) CEO Daniel Browne on Q2 2019 Results - Earnings Call TranscriptSeeking Alpha • 08/06/19
Will Revance Therapeutics (RVNC) Report Negative Q2 Earnings? What You Should KnowZacks Investment Research • 07/25/19
Revance Therapeutics, Inc. (RVNC) on Q1 2019 Results - Earnings Call TranscriptSeeking Alpha • 05/09/19